Nasdaq News

This year has not been kind to companies with weak balance sheets. Fallout from the COVID-19 pandemic has triggered bankruptcies in many market sectors, with particularly heavy tolls on brick-and-mortar retailers and oil producers. Entire countries like Zambia and Suriname are r

Earlier this month, Bed Bath & Beyond (NASDAQ: BBBY) reported dreadful results for the first quarter of fiscal 2020. Revenue plunged by nearly half due to the COVID-19 pandemic, while gross margin fell to just 26.7%, compared to 34.5% in the prior-year period. As a result, t

The market didn’t get the Friday flourish that it needed to stage a comeback and save this volatile week. As a result, the Dow and S&P saw their three-week winning streaks come to an end today. And the NASDAQ? It now has a two-week losing skid as the once-untouchable te

Facebook (NASDAQ: FB) was already facing difficulties from reduced marketing budgets as a result of COVID-19 before large public companies started announcing that they would pause advertising on Facebook in support of the Stop Hate for Profit campaign, which criticizes Facebook

Investing in innovative drugs and therapies that treat patients with highly unmet medical needs can be a rewarding venture. Indeed, year to date, the iShares Nasdaq Biotechnology ETF (NASDAQ: IBB) has returned nearly 20%. During the same period, the S&P 500 index has gained

Not too long ago Healthpeak Properties (NYSE: PEAK) was the laggard in its diversified real estate investment trust (REIT) peer group. Today it looks better positioned than its closest peers. Here's what happened, and why, if you are looking for a diversified REIT today, you mig

NextEra Energy Partners (NYSE: NEP) generated excellent results during the second quarter despite the market turmoil caused by COVID-19. Underlying the company's strength were its strong contract profile, solidly performing existing assets, and several recent acquisitions. Beca

As we all know, Apple is one of the most successful companies of all time. Since its initial public offering in 1980, its shares have gone on to appreciate almost 1,000 times over -- and that's not even including dividends, which Apple has been paying since 2012.

Garmin (NASDAQ: GRMN) stock has tracked right along with the market so far in 2020, first swooning as the S&P 500 dove in late March and then rallying right back to positive territory in early July. Investors appear to believe the GPS device giant's growth will be dependent

It's been a volatile year in the markets, and the S&P 500's returns are flat year to date. While that's good news for investors who were fearing the worst (a prolonged market crash) in March, 2020's still been a lousy year for many stocks. But two stocks have been the except

BP (NYSE: BP), formerly known as British Petroleum, is shaking things up in the middle of a deep industry downturn. On the surface, the changes it's making are good news -- but when you dig in a little bit deeper, there are risks that could play out over the longer term. Here ar

I've never been bearish on JPMorgan Chase (NYSE: JPM) long-term, but in the past few months, I've been worried about the kinds of problems the bank might run into in the short term. After all, America's largest bank is a leading lender to the struggling oil industry and has a ma

From what you've heard in the news, you might get the idea that investors who use the Robinhood trading app don't stand a chance of making money. It's true that some day traders use Robinhood as their platform, and some of their favorite stock picks leave much to be desired.

We've been reading about it for years, but the e-commerce revolution is truly heating up in 2020. Nonstore retail is a category that includes online shopping, and it's growing like crazy. According to the U.S. Census Bureau, total retail and food-service sales from April through

Slack (NYSE: WORK) recently filed an antitrust complaint against Microsoft (NASDAQ: MSFT) in the European Union, claiming Microsoft's strategy of bundling Teams into Office 365 is anti-competitive.

Which stocks are best to own during a market crash? To find out, we can look to ones that demonstrated strength in the most recent crash. Often, the winners are those with market leadership. If demand for their products or services remains strong in spite of economic upset, that

When COVID-19 first took hold back in March, the stock market reacted almost instantly, plunging into bear market territory for the first time in over a decade. But stock values have recovered nicely since then, to the point where you almost wouldn't think we're in a recession.

Many investors believe that stocks will revert to the mean: What goes up will come down, and what goes down will come up. This belief is profoundly untrue. Stocks that have dropped often continue to drop after you buy them. Buying a stock that has lost a great deal of money for

Fifth-generation "stealthy" fighter jets, invisible to radar, capable of flying unimpeded into hostile territory to hit their targets and come home safe -- how great is that? Who wouldn't want to own a whole flock of them? There's just one little problem: the price tag.

CRISPR gene editing became a big story around 2012, and in the few years that followed, the promise of the technology spurred the founding of several biotechs focused on using it to treat diseases. Editas Medicine (NASDAQ: EDIT) was one of them.